Bursa Malaysia is expected to trend higher next week

https://www.malaymail.com/news/money/2020/12/12/bursa-malaysia-is-expected-to-trend-higher-next-week/1931258

----------------

Bursa Malaysia expected to break 1,700 psychological level

Bursa Malaysia is expected to trend higher next week, with the key FTSE Bursa Malaysia KLCI (FBM KLCI) breaking the psychological level of 1,700, and poised to march into the new year with a big bang.

https://themalaysianreserve.com/2020/12/12/bursa-malaysia-expected-to-break-1700-psychological-level/

Bursa Malaysia is expected to trend higher next week

https://www.malaymail.com/news/money/2020/12/12/bursa-malaysia-is-expected-to-trend-higher-next-week/1931258

----------------

Bursa Malaysia expected to break 1,700 psychological level

Bursa Malaysia is expected to trend higher next week, with the key FTSE Bursa Malaysia KLCI (FBM KLCI) breaking the psychological level of 1,700, and poised to march into the new year with a big bang.

https://themalaysianreserve.com/2020/12/12/bursa-malaysia-expected-to-break-1700-psychological-level/

Bursa Malaysia is expected to trend higher next week

https://www.malaymail.com/news/money/2020/12/12/bursa-malaysia-is-expected-to-trend-higher-next-week/1931258

----------------

Bursa Malaysia expected to break 1,700 psychological level

Bursa Malaysia is expected to trend higher next week, with the key FTSE Bursa Malaysia KLCI (FBM KLCI) breaking the psychological level of 1,700, and poised to march into the new year with a big bang.

https://themalaysianreserve.com/2020/12/12/bursa-malaysia-expected-to-break-1700-psychological-level/

Bursa Malaysia is expected to trend higher next week

https://www.malaymail.com/news/money/2020/12/12/bursa-malaysia-is-expected-to-trend-higher-next-week/1931258

----------------

Bursa Malaysia expected to break 1,700 psychological level

Bursa Malaysia is expected to trend higher next week, with the key FTSE Bursa Malaysia KLCI (FBM KLCI) breaking the psychological level of 1,700, and poised to march into the new year with a big bang.

https://themalaysianreserve.com/2020/12/12/bursa-malaysia-expected-to-break-1700-psychological-level/

Bursa Malaysia is expected to trend higher next week

https://www.malaymail.com/news/money/2020/12/12/bursa-malaysia-is-expected-to-trend-higher-next-week/1931258

----------------

Bursa Malaysia expected to break 1,700 psychological level

Bursa Malaysia is expected to trend higher next week, with the key FTSE Bursa Malaysia KLCI (FBM KLCI) breaking the psychological level of 1,700, and poised to march into the new year with a big bang.

https://themalaysianreserve.com/2020/12/12/bursa-malaysia-expected-to-break-1700-psychological-level/

Bursa Malaysia is expected to trend higher next week

https://www.malaymail.com/news/money/2020/12/12/bursa-malaysia-is-expected-to-trend-higher-next-week/1931258

----------------

Bursa Malaysia expected to break 1,700 psychological level

Bursa Malaysia is expected to trend higher next week, with the key FTSE Bursa Malaysia KLCI (FBM KLCI) breaking the psychological level of 1,700, and poised to march into the new year with a big bang.

https://themalaysianreserve.com/2020/12/12/bursa-malaysia-expected-to-break-1700-psychological-level/

Bursa Malaysia is expected to trend higher next week

https://www.malaymail.com/news/money/2020/12/12/bursa-malaysia-is-expected-to-trend-higher-next-week/1931258

----------------

Bursa Malaysia expected to break 1,700 psychological level

Bursa Malaysia is expected to trend higher next week, with the key FTSE Bursa Malaysia KLCI (FBM KLCI) breaking the psychological level of 1,700, and poised to march into the new year with a big bang.

https://themalaysianreserve.com/2020/12/12/bursa-malaysia-expected-to-break-1700-psychological-level/

Bursa Malaysia is expected to trend higher next week

https://www.malaymail.com/news/money/2020/12/12/bursa-malaysia-is-expected-to-trend-higher-next-week/1931258

----------------

Bursa Malaysia expected to break 1,700 psychological level

Bursa Malaysia is expected to trend higher next week, with the key FTSE Bursa Malaysia KLCI (FBM KLCI) breaking the psychological level of 1,700, and poised to march into the new year with a big bang.

https://themalaysianreserve.com/2020/12/12/bursa-malaysia-expected-to-break-1700-psychological-level/

Bursa Malaysia is expected to trend higher next week

https://www.malaymail.com/news/money/2020/12/12/bursa-malaysia-is-expected-to-trend-higher-next-week/1931258

----------------

Bursa Malaysia expected to break 1,700 psychological level

Bursa Malaysia is expected to trend higher next week, with the key FTSE Bursa Malaysia KLCI (FBM KLCI) breaking the psychological level of 1,700, and poised to march into the new year with a big bang.

https://themalaysianreserve.com/2020/12/12/bursa-malaysia-expected-to-break-1700-psychological-level/

Bursa Malaysia is expected to trend higher next week

https://www.malaymail.com/news/money/2020/12/12/bursa-malaysia-is-expected-to-trend-higher-next-week/1931258

----------------

Bursa Malaysia expected to break 1,700 psychological level

Bursa Malaysia is expected to trend higher next week, with the key FTSE Bursa Malaysia KLCI (FBM KLCI) breaking the psychological level of 1,700, and poised to march into the new year with a big bang.

https://themalaysianreserve.com/2020/12/12/bursa-malaysia-expected-to-break-1700-psychological-level/

Bursa Malaysia is expected to trend higher next week

https://www.malaymail.com/news/money/2020/12/12/bursa-malaysia-is-expected-to-trend-higher-next-week/1931258

----------------

Bursa Malaysia expected to break 1,700 psychological level

Bursa Malaysia is expected to trend higher next week, with the key FTSE Bursa Malaysia KLCI (FBM KLCI) breaking the psychological level of 1,700, and poised to march into the new year with a big bang.

https://themalaysianreserve.com/2020/12/12/bursa-malaysia-expected-to-break-1700-psychological-level/

@MInvestor Emergency authorization of Pfizer vaccine was only given by FDA on Friday in USA

@MInvestor Emergency authorization of Pfizer vaccine was only given by FDA on Friday in USA

Pfizer Vaccine Cleared in U.S., a Landmark in Covid-19 Fight

Pfizer Inc. gained emergency U.S. authorization for its Covid-19 vaccine on Friday, completing an unprecedented scientific sprint that could eventually help bring an end to a pandemic that has killed nearly 300,000 Americans

https://www.bloomberg.com/news/articles/2020-12-12/pfizer-covid-vaccine-wins-u-s-fda-emergency-use-authorization

Pfizer Vaccine Cleared in U.S., a Landmark in Covid-19 Fight

Pfizer Inc. gained emergency U.S. authorization for its Covid-19 vaccine on Friday, completing an unprecedented scientific sprint that could eventually help bring an end to a pandemic that has killed nearly 300,000 Americans

https://www.bloomberg.com/news/articles/2020-12-12/pfizer-covid-vaccine-wins-u-s-fda-emergency-use-authorization

Pfizer Vaccine Cleared in U.S., a Landmark in Covid-19 Fight

Pfizer Inc. gained emergency U.S. authorization for its Covid-19 vaccine on Friday, completing an unprecedented scientific sprint that could eventually help bring an end to a pandemic that has killed nearly 300,000 Americans

https://www.bloomberg.com/news/articles/2020-12-12/pfizer-covid-vaccine-wins-u-s-fda-emergency-use-authorization

Pfizer Vaccine Cleared in U.S., a Landmark in Covid-19 Fight

Pfizer Inc. gained emergency U.S. authorization for its Covid-19 vaccine on Friday, completing an unprecedented scientific sprint that could eventually help bring an end to a pandemic that has killed nearly 300,000 Americans

https://www.bloomberg.com/news/articles/2020-12-12/pfizer-covid-vaccine-wins-u-s-fda-emergency-use-authorization

Pfizer Vaccine Cleared in U.S., a Landmark in Covid-19 Fight

Pfizer Inc. gained emergency U.S. authorization for its Covid-19 vaccine on Friday, completing an unprecedented scientific sprint that could eventually help bring an end to a pandemic that has killed nearly 300,000 Americans

https://www.bloomberg.com/news/articles/2020-12-12/pfizer-covid-vaccine-wins-u-s-fda-emergency-use-authorization

Pfizer Vaccine Cleared in U.S., a Landmark in Covid-19 Fight

Pfizer Inc. gained emergency U.S. authorization for its Covid-19 vaccine on Friday, completing an unprecedented scientific sprint that could eventually help bring an end to a pandemic that has killed nearly 300,000 Americans

https://www.bloomberg.com/news/articles/2020-12-12/pfizer-covid-vaccine-wins-u-s-fda-emergency-use-authorization

Pfizer Vaccine Cleared in U.S., a Landmark in Covid-19 Fight

Pfizer Inc. gained emergency U.S. authorization for its Covid-19 vaccine on Friday, completing an unprecedented scientific sprint that could eventually help bring an end to a pandemic that has killed nearly 300,000 Americans

https://www.bloomberg.com/news/articles/2020-12-12/pfizer-covid-vaccine-wins-u-s-fda-emergency-use-authorization

Pfizer Vaccine Cleared in U.S., a Landmark in Covid-19 Fight

Pfizer Inc. gained emergency U.S. authorization for its Covid-19 vaccine on Friday, completing an unprecedented scientific sprint that could eventually help bring an end to a pandemic that has killed nearly 300,000 Americans

https://www.bloomberg.com/news/articles/2020-12-12/pfizer-covid-vaccine-wins-u-s-fda-emergency-use-authorization

Pfizer Vaccine Cleared in U.S., a Landmark in Covid-19 Fight

Pfizer Inc. gained emergency U.S. authorization for its Covid-19 vaccine on Friday, completing an unprecedented scientific sprint that could eventually help bring an end to a pandemic that has killed nearly 300,000 Americans

https://www.bloomberg.com/news/articles/2020-12-12/pfizer-covid-vaccine-wins-u-s-fda-emergency-use-authorization

Pfizer Vaccine Cleared in U.S., a Landmark in Covid-19 Fight

Pfizer Inc. gained emergency U.S. authorization for its Covid-19 vaccine on Friday, completing an unprecedented scientific sprint that could eventually help bring an end to a pandemic that has killed nearly 300,000 Americans

https://www.bloomberg.com/news/articles/2020-12-12/pfizer-covid-vaccine-wins-u-s-fda-emergency-use-authorization

Pfizer Vaccine Cleared in U.S., a Landmark in Covid-19 Fight

Pfizer Inc. gained emergency U.S. authorization for its Covid-19 vaccine on Friday, completing an unprecedented scientific sprint that could eventually help bring an end to a pandemic that has killed nearly 300,000 Americans

https://www.bloomberg.com/news/articles/2020-12-12/pfizer-covid-vaccine-wins-u-s-fda-emergency-use-authorization

Pfizer Vaccine Cleared in U.S., a Landmark in Covid-19 Fight

Pfizer Inc. gained emergency U.S. authorization for its Covid-19 vaccine on Friday, completing an unprecedented scientific sprint that could eventually help bring an end to a pandemic that has killed nearly 300,000 Americans

https://www.bloomberg.com/news/articles/2020-12-12/pfizer-covid-vaccine-wins-u-s-fda-emergency-use-authorization

Pfizer Vaccine Cleared in U.S., a Landmark in Covid-19 Fight

Pfizer Inc. gained emergency U.S. authorization for its Covid-19 vaccine on Friday, completing an unprecedented scientific sprint that could eventually help bring an end to a pandemic that has killed nearly 300,000 Americans

https://www.bloomberg.com/news/articles/2020-12-12/pfizer-covid-vaccine-wins-u-s-fda-emergency-use-authorization

Pfizer Vaccine Cleared in U.S., a Landmark in Covid-19 Fight

Pfizer Inc. gained emergency U.S. authorization for its Covid-19 vaccine on Friday, completing an unprecedented scientific sprint that could eventually help bring an end to a pandemic that has killed nearly 300,000 Americans

https://www.bloomberg.com/news/articles/2020-12-12/pfizer-covid-vaccine-wins-u-s-fda-emergency-use-authorization

WARNING :

For your information....GI HEALTHCARE RESOURCES SDN. BHD is not even registered for business. Just incorporated co name only.

----------------

Name: GI HEALTHCARE RESOURCES SDN. BHD.
Registration No. : 202001010663 (1366983-D)
Incorporation Date: 30-04-2020
Registration Date: Nil
Fees paid: RM 100
Share issued: Nil

Note:
This is a shelf company without any paid up capital. It is also not registered for commencement of business. The above info is obtained from SSM Company Search.

@Noobie123 Thanks for sacrificing RM30 search fee to obtain the information below. Much appreciated....

----------------------------------------
Noobie123 Name: GI HEALTHCARE RESOURCES SDN. BHD.
Registration No. : 202001010663 (1366983-D)
Incorporation Date: 30-04-2020
Registration Date: Nil
Fees paid: RM 100
Share issued: Nil

Note:
This is a shelf company without any paid up capital. It is also not registered for commencement of business. The above info is obtained from SSM Company Search.

@UlarSawa

Reposting as per your request.....

---------------------------------

https://www.mida.gov.my/home/11074/news/kanger-international-poised-to-be-world%E2%80%99s-largest-producer-of-bamboo-products/
https://www.mida.gov.my/home/11079/news/kanger-poised-to-become-top-global-manufacturer-of-bamboo-products/
https://www.mida.gov.my/home/10966/news/kanger-seals-deal-to-venture-into-glove-sector/
https://www.mida.gov.my/home/10974/news/four-more-companies-plan-to-join-the-rubber-glove-makers-club/
http://www.myrubbercouncil.com/news/industrynews.php

@UlarSawa Reposting it as per your request...

------------------------------
Kanger potential revenue streams aside from distribution of Covid-19 vaccine and medical equipments from Sinopharm Group are as follows :

1) Manufacture and trading of bamboo flooring and related products :
Kanger International poised to be world’s largest producer of bamboo products

https://www.malaymail.com/news/money/2020/09/08/kanger-international-poised-to-be-worlds-largest-producer-of-bamboo-product/1901354

2) The Group (Kanger Group) being the sole exclusive distributor in the China for "Classen", a brand of a high-end wood flooring products originated from Germany, and will continue to focus its efforts to promote and sell Classen's products.

With rising acceptance of the Classen brand in China, Kanger was recently presented with the Excellence Award for Best Supplier to the Chinese Bed & Breakfast Industry at the 2019 International B&B Industry Development Forum and the 2019-2020 Illustrious Brand award by the China Renovation & Construction Alliance.

Sales of Classen products have been encouraging and proved to be a good complement to the group, generating revenue to the group whilst the group scaled down its production of in-house bamboo products to make way for the relocation exercise of the bamboo plant.

https://disclosure.bursamalaysia.com/FileAccess/apbursaweb/download?id=107904&name=EA_GA_ATTACHMENTS

https://www.thestar.com.my/business/business-news/2020/09/09/kanger-international-on-track-to-be-largest-producer-of-bamboo-products

3) Kanger International Bhd has completed the development of AutoCity and Kyriad Hotel in China worth RM500 million collectively. In March, Kanger had secured 10-year lease agreements for AutoCity and Kyriad Hotel.

https://www.nst.com.my/property/2020/08/618182/kanger-completes-autocity-and-business-hotel-china-rm500-million

4) Kanger to facilitate sand exports to mainland China, Hong Kong

https://www.theedgemarkets.com/article/kanger-facilitate-sand-exports-mainland-china-hong-kong

5) Kanger to distribute antimicrobial coating solutions locally and overseas

https://www.theedgemarkets.com/article/kanger-distribute-antimicrobial-coating-solutions-locally-and-overseas

6) Kanger invests RM77mil on glove factory (Not sure what is the latest status of this glove factory)
The group will invest RM77 million to set up the plant in Ijok, Selangor, and produce at least one billion pieces of gloves per annum.

Wu has said the group is targeting to start full production in the first quarter of 2021 as there are pipeline orders in the Middle East.

It was reported that Kanger will invest RM77 million to set up a glove manufacturing plant in Ijok, Selangor next year. It will acquire five acres in Ijok for RM6.8 million through its wholly owned unit Kanger Glove Manufacturing Sdn Bhd. Kanger Glove will spend about RM70 million to build the plant and install 8 production lines to produce medical, surgical and/or nitrile gloves for the Middle East region.

The 8 production lines are expected to produce at least one billion pieces of gloves per annum.
In a filing with Bursa Malaysia in August, Kanger had said that a substantial proportion of the total output of the production will be sold to Dubai-based Constellation Holdings Ltd (CHL).

https://www.nst.com.my/business/2020/08/616658/kanger-invests-rm77mil-glove-factory
https://www.nst.com.my/property/2020/08/618182/kanger-completes-autocity-and-business-hotel-china-rm500-million
https://mymntnews.com/2020/09/14/kanger-international-bhd-a-must-watch-stock-for-the-week/

Pfizer Vaccine Cleared in U.S., a Landmark in Covid-19 Fight

Pfizer Inc. gained emergency U.S. authorization for its Covid-19 vaccine on Friday, completing an unprecedented scientific sprint that could eventually help bring an end to a pandemic that has killed nearly 300,000 Americans

https://www.bloomberg.com/news/articles/2020-12-12/pfizer-covid-vaccine-wins-u-s-fda-emergency-use-authorization

Pfizer Vaccine Cleared in U.S., a Landmark in Covid-19 Fight

Pfizer Inc. gained emergency U.S. authorization for its Covid-19 vaccine on Friday, completing an unprecedented scientific sprint that could eventually help bring an end to a pandemic that has killed nearly 300,000 Americans

https://www.bloomberg.com/news/articles/2020-12-12/pfizer-covid-vaccine-wins-u-s-fda-emergency-use-authorization

Pfizer Vaccine Cleared in U.S., a Landmark in Covid-19 Fight

Pfizer Inc. gained emergency U.S. authorization for its Covid-19 vaccine on Friday, completing an unprecedented scientific sprint that could eventually help bring an end to a pandemic that has killed nearly 300,000 Americans

https://www.bloomberg.com/news/articles/2020-12-12/pfizer-covid-vaccine-wins-u-s-fda-emergency-use-authorization

Pfizer Vaccine Cleared in U.S., a Landmark in Covid-19 Fight

Pfizer Inc. gained emergency U.S. authorization for its Covid-19 vaccine on Friday, completing an unprecedented scientific sprint that could eventually help bring an end to a pandemic that has killed nearly 300,000 Americans

https://www.bloomberg.com/news/articles/2020-12-12/pfizer-covid-vaccine-wins-u-s-fda-emergency-use-authorization

Pfizer Vaccine Cleared in U.S., a Landmark in Covid-19 Fight

Pfizer Inc. gained emergency U.S. authorization for its Covid-19 vaccine on Friday, completing an unprecedented scientific sprint that could eventually help bring an end to a pandemic that has killed nearly 300,000 Americans

https://www.bloomberg.com/news/articles/2020-12-12/pfizer-covid-vaccine-wins-u-s-fda-emergency-use-authorization

Pfizer Vaccine Cleared in U.S., a Landmark in Covid-19 Fight

Pfizer Inc. gained emergency U.S. authorization for its Covid-19 vaccine on Friday, completing an unprecedented scientific sprint that could eventually help bring an end to a pandemic that has killed nearly 300,000 Americans

https://www.bloomberg.com/news/articles/2020-12-12/pfizer-covid-vaccine-wins-u-s-fda-emergency-use-authorization

Pfizer Vaccine Cleared in U.S., a Landmark in Covid-19 Fight

Pfizer Inc. gained emergency U.S. authorization for its Covid-19 vaccine on Friday, completing an unprecedented scientific sprint that could eventually help bring an end to a pandemic that has killed nearly 300,000 Americans

https://www.bloomberg.com/news/articles/2020-12-12/pfizer-covid-vaccine-wins-u-s-fda-emergency-use-authorization

Pfizer Vaccine Cleared in U.S., a Landmark in Covid-19 Fight

Pfizer Inc. gained emergency U.S. authorization for its Covid-19 vaccine on Friday, completing an unprecedented scientific sprint that could eventually help bring an end to a pandemic that has killed nearly 300,000 Americans

https://www.bloomberg.com/news/articles/2020-12-12/pfizer-covid-vaccine-wins-u-s-fda-emergency-use-authorization

Pfizer Vaccine Cleared in U.S., a Landmark in Covid-19 Fight

Pfizer Inc. gained emergency U.S. authorization for its Covid-19 vaccine on Friday, completing an unprecedented scientific sprint that could eventually help bring an end to a pandemic that has killed nearly 300,000 Americans

https://www.bloomberg.com/news/articles/2020-12-12/pfizer-covid-vaccine-wins-u-s-fda-emergency-use-authorization

Pfizer Vaccine Cleared in U.S., a Landmark in Covid-19 Fight

Pfizer Inc. gained emergency U.S. authorization for its Covid-19 vaccine on Friday, completing an unprecedented scientific sprint that could eventually help bring an end to a pandemic that has killed nearly 300,000 Americans

https://www.bloomberg.com/news/articles/2020-12-12/pfizer-covid-vaccine-wins-u-s-fda-emergency-use-authorization

Pfizer Vaccine Cleared in U.S., a Landmark in Covid-19 Fight

Pfizer Inc. gained emergency U.S. authorization for its Covid-19 vaccine on Friday, completing an unprecedented scientific sprint that could eventually help bring an end to a pandemic that has killed nearly 300,000 Americans

https://www.bloomberg.com/news/articles/2020-12-12/pfizer-covid-vaccine-wins-u-s-fda-emergency-use-authorization

Is Constellation Holdings Ltd the 3rd party investor of the private placement shares ?

---------------------

In a statement yesterday, Kanger International Bhd said it had received a formal expression of interest (EOI) letter from Dubai firm Constellation Holdings Ltd to set up medical examination gloves operations in Malaysia.

Constellation is the appointed procurement agent for personal protective equipment (PPE), medical equipment and supplies for the United Arab Emirates’ Ministry of Health and Prevention, as well as other Middle Eastern countries.

The group proposes to collaborate via direct equity participation in a joint-venture (JV) entity and/or indirect equity holding in the glove manufacturing operations via investment into Kanger through a PRIVATE PLACEMENT EXCERCISE, whereby Constellation will seek to become a substantial shareholder of Kanger.

Kanger ED Joseph Wu Wai Kong said the medical gloves factory will be established locally due to easy access to raw materials, manpower, technical know-how and management experience.

“By collaborating with a major medical buyer representing governments in the Middle Eastern region, we would be able to tap into their wide customer network to secure long-term supply agreements,” he added.

https://themalaysianreserve.com/2020/08/12/bandwagon-of-new-glovemakers/

https://disclosure.bursamalaysia.com/FileAccess/apbursaweb/download?id=106005&name=EA_GA_ATTACHMENTS

Information below is from the Malaysian Rubber Council (MRC) website.

The Malaysian Rubber Council (MRC) was incorporated on 14 April 2000 under the Companies Act 1965 as a company limited by guarantee under the Ministry of Plantation Industries and Commodities (MPIC).

MRC is governed by a Board of Trustees appointed by the Minister of Plantation Industries and Commodities. MRC is tasked with undertaking market promotion of quality Malaysian rubber products in world markets, and supports small and medium enterprises (SMEs) through domestic promotion efforts.

-------------
Kanger to Build Glove Plant for Exports

Kanger International Bhd will invest RM77 million to set up a glove manufacturing plant in Ijok, Selangor as early as next year and export the output to the Arab region. Kanger will acquire five acres in Ijok for RM6.8 million through its wholly owned Kanger Glove Manufacturing Sdn Bhd. Kanger Glove will spend about RM70 million to build the plant and install up to eight production lines to produce medical, surgical and/or nitrile gloves.

http://www.myrubbercouncil.com/news/industrynews.php

Found a photo of Mr. Wu Wai Kong haha

https://www.pressreader.com/malaysia/new-straits-times/20191225/281681141786778

"River sand is a widely used construction material and is in short supply in China and Hong Kong due to the rapid pace of construction and reclamation works there," he said in a statement today.

https://www.nst.com.my/business/2020/06/603131/kib-llsb-collaborate-export-river-sand-china-hong-kong

Another writeup on MIDA's website :

Kanger International Bhd also unveiled that it had received a formal expression of interest from Dubai-based Constellation Holdings Ltd (a procurement agent for PPE and medical equipment to the United Arab Emirates' Ministry of Health and Prevention). Kanger said Constellation was willing to collaborate either through: direct equity participation, such as a JV; or indirect equity holdings via an investment in Kanger, whereby the Emirati company becomes a substantial shareholder through a private placement.

https://www.mida.gov.my/home/10974/news/four-more-companies-plan-to-join-the-rubber-glove-makers-club/

Another writeup on Kanger on MIDA website.

----------------------
Kanger poised to become top global manufacturer of bamboo products
​ACE Market-listed Kanger International Bhd is poised to become the world’s top manufacturer of bamboo products, thanks to its 70:30 collaboration with the Jingzhou local government in the Hunan Province, China
ACE Market-listed Kanger International Bhd is poised to become the world’s top manufacturer of bamboo products, thanks to its 70:30 collaboration with the Jingzhou local government in the Hunan Province, China.

Newly-appointed executive director Steven Kuah Choon Ching said testing works are being carried out at its new RM121 million plant in Jingzhou, with full commercial production set to commence in the fourth quarter of this year.

“We are in a strong position to significantly upscale our bamboo processing business to become one of the world’s largest integrated bamboo producers in the world, with both upstream (plantation) and downstream (processing, manufacturing and distribution) capabilities,” he said in a statement today.

Equipped with a research and development centre, the Jingzhou facility has adopted the latest modern processing methods capable of processing raw bamboo into a wide variety of products such as bamboo furniture, flooring and building materials.

Kuah said the Jingzhou government is injecting into the private-public partnership a bamboo plantation concession, with a total coverage area of approximately 8,430.81 hectares over three phases, beginning with an initial 2,428.11 hectares of fully matured bamboo.

The company estimated that it would take up to three years to process all of the ready-to-harvest raw bamboos into bamboo flooring, furniture and building materials, which could potentially generate a total revenue of 800 million Chinese renminbi (1 renminbi=RM0.61) over the three-year period.

“Kanger’s market research estimates the value of the global bamboo market at US$68.8 billion (RM288.8 billion) in 2018, given that it is widely used to make furniture, sculptures, floorings and walls in hotels and resorts all over the world,” it said.

To support this venture, Kuah said Kanger has established a large distribution network of over 100 dealer stores across China, implementing online-to-offline marketing and delivery channels as well as having its presence in a number of online platforms, including JD.com, Alibaba’s Taobao and WeChat.

“To grow the export market, Kanger will be opening new international showrooms in Asia, the Middle East, Europe and North America,” he said.

In Malaysia, Kanger has set its sights on establishing new revenue streams with the recent purchase of a parcel of land measuring 2.22 hectares in Kuala Selangor for RM6.8 million.

“The group is actively looking out for strategic opportunities with attractive prospects to invest in,” added Kuah.

Source: Bernama

Posted on : 09 September 2020

https://www.mida.gov.my/home/11079/news/kanger-poised-to-become-top-global-manufacturer-of-bamboo-products/

Another writeup on Kanger regarding their plant to venture into glove sector.

---------------------------

Kanger seals deal to venture into glove sector

​Kanger International Bhd, which diversified into property investment and management to reduce its sole reliance on its current core business, may venture into medical examination gloves operations
Kanger International Bhd, which diversified into property investment and management to reduce its sole reliance on its current core business, may venture into medical examination gloves operations.

The company today said it had received a formal expression of interest (EOI) from a company in Dubai to set up a medical examination gloves operations in Malaysia.

In a filing with Bursa Malaysia, Kanger said it had received the EOI, dated August 9 from Constellation Holdings Ltd.

Constellation is the appointed procurement agent for personal protective equipment, medical equipment and supplies for the Ministry of Health & Prevention of the United Arab Emirates, and other countries in the Middle Eastern region.

The EOI expresses Constellation's intention to collaborate with Kanger through several options.

This includes direct equity participation by forming a joint-venture entity, and/or indirect equity holding in the glove manufacturing operations via investment into Kanger through a private placement exercise.

Kanger said the private placement would result in Constellation becoming a substantial shareholder in it.

"The board is considering the proposals set forth in the EOI and will continue to engage with Constellation to achieve an outcome that is in the best interest of the company and all stakeholders," it said.

Kanger, which manufactures bamboo wood products, has been seeking to diversify its income stream.

In March, the company announced that it had secured 10-year lease agreements for two of its commercial buildings located within the Ganzhou Economic and Technological Development Zone in Ganzhou city, China.

Kanger is leasing AutoCity, a purpose-built six-storey building with a net lettable area (NLA) of 493,062 sq ft, and a 19-storey hotel with an NLA of 190,715 sq ft.

The two properties are owned by Kanger's indirect wholly-owned subsidiary Ganzhou Kanger Industrial Co Ltd.

Source: NST

Posted on : 11 August 2020

https://www.mida.gov.my/home/10966/news/kanger-seals-deal-to-venture-into-glove-sector/